Aspen’s South African subsidiary Aspen Pharmacare has signed a preliminary agreement with two Johnson & Johnson (J&J) subsidiaries for the technical transfer and proposed commercial manufacture of their Covid-19 vaccine candidate.
On Friday, August 18, 2017, Aspen Pharmacare Canada officially completed the transfer of Canadian commercialization rights associated with five of AstraZeneca's anesthetic products.